Novavax Gains US FDA Advisory Committee Endorsement, But So Does Myocarditis Risk Statement

 
• By Derrick Gingery
FDA vaccines advisory committee meeting screenshot
The Vaccines and Related Biological Products Advisory Committee vote on the Novavax COVID-19 vaccine is announced during the 7 June meeting. • Source: screenshot

More from US FDA Performance Tracker

More from Regulatory Trackers